Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial-Reference-Cited by-同舟云学术

Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial

Published:2021-01-15 Issue:6 Volume:56 Page:1413-1421
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Pettengell R.^ORCID,Uddin R.,Boumendil A.,Johnson R.,Metzner B.,Martín A.,Romejko-Jarosinska J.,Bence-Bruckler I.,Giri P.,Niemann C. U.,Robinson S. P.,Kimby E.,Schmitz N.,Dreger P.^ORCID,Goldstone A. H.,Montoto S.

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-020-01182-w.pdf

Reference31 articles.

1. Alperovich A, Batlevi C, Smith K, Ying Z, Soumerai JD, Copeland AR, et al. Benchmark of progression free survival for multiple lines of therapy in follicular lymphoma treated in the rituximab era. Blood. 2016;128:2955.

2. Casulo C, Byrtek M, Dawson KL, Zhou X, Farber CM, Flowers CR, et al. Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: an analysis from the National LymphoCare study. J Clin Oncol. 2015;33:2516–22.

3. Jurinovic V, Metzner B, Pfreundschuh M, Schmitz N, Wandt H, Keller U, et al. Autologous Stem Cell Transplantation for Patients with Early Progression of Follicular Lymphoma: a Follow-Up Study of 2 Randomized Trials from the German Low Grade Lymphoma Study Group. Biol Blood Marrow Transplant. 2018;24:1172–9.

4. Al Khabori M, de Almeida JR, Guyatt GH, Kuruvilla J, Crump M. Autologous stem cell transplantation in follicular lymphoma: a systematic review and meta-analysis. J Natl Cancer Inst. 2012;104:18–28.

5. Oh DH, Li H, Duan Q, Villa D, Peters A, Chua N, et al. Quantifying Benefit of Autologous Transplantation for Relapsed Follicular Lymphoma Patients via Instrumental Variable Analysis. Biol Blood Marrow Transplant. 2016;22:941–8.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age and lymphocyte/monocyte ratio as prognostic factors for autologous transplantation in the treatment of patients with follicular lymphoma;Journal of International Medical Research;2024-02

2. Indolent Lymphoma;The EBMT Handbook;2024

3. Treatment of relapsed follicular lymphoma;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

4. Follicular lymphoma: an update on biology and optimal therapy;Leukemia & Lymphoma;2023-02-09

5. Long‐term follow‐up demonstrates curative potential of autologous stem cell transplantation for relapsed follicular lymphoma;British Journal of Haematology;2023-01-10